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Inflammation: More Than One
Explanation
I read with interest the EHPsupplement
on oxygen radicals and lung injury (vol.
102, supplement 10). I would like to
take this opportunity to comment about
this supplement and raise a key issue
concerning the major concepts regarding
the mechanisms of cellular injury in
inflammatory diseases.
As an active investigator in this field
of research, I cannot fully understand
why there was no mention in the supple-
ment about the basic understanding that
cellular damage in inflammation is multi-
factorial. The nonexpert reader of this
supplement might receive an erroneous
impression that oxygen radicals, per se,
are the exclusive toxic agonists that
induce cellular injury. Many in this field
share the view that cellular damage in
inflammatory diseases might be caused
by a "coordinated cross-talk" among oxi-
dants, membrane-damaging agents, pro-
teinases, arachidonic acid metabolites,
phospholipases, cationic proteins, and
cytokines. All these agents are likely to be
present in sites of infection and inflam-
mation. But sadly, none of the publica-
tions elaborating on this multifactorial
view are quoted in modern textbooks or
in symposia on inflammation and
inflammatory diseases. Instead, the litera-
ture is filled with publications that insist
on a single agonist, be it an oxidant, a
protease, a cytokine, etc., in experimental
models. No attempt to integrate the vari-
ous agonists into the full picture is made.
Several ofour publications (1-7) deal
with synergistic interactions among mul-
tiple proinflammatory agonists in cellular
injury during inflammation. I believe
that this issue is important, timely, and
might contribute to an understanding of
how drugs, chemicals, and xenobiotics
function in vivo.
Isaac Ginsburg
Hadassah School ofDental Medicine
Hebrew University
Jerusalem
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Response
We appreciate the interest shown by Dr.
Ginsburg in our recent conference proceed-
ings (EHP 102, supplement 10). As stated
in the preface of those proceedings, The
Oxygen Radicals and Lung Injury
Conference was the first ofits kind dedicat-
ed to pulmonary science. Therefore, in this
conference, the primary attempt was to
focus on oxygen radicals and their involve-
ment in toxic insults and the ensuing patho-
physiological processes in the lung. We did
not ignore the importance of multifactorial
relationships of other cellular reactions and
products involved in cellular damage and
injury. In fact, these issues were addressed in
the presentations ofWard (1), Holian et al.
(2), Repine (3), Torphy et al. (4), and
Demers and Kuhn (5). The complex net-
work of micromolecular reactions have not
been fully defined to understand the coordi-
nation, modulation, and integration of cel-
lular functions. In manypulmonary diseases
(e.g., cancer, emphysema, pneumoconiosis)
in which oxygen radicals are implicated, the
disease becomes evident only after several
years. Subtle damage or changes to biomole-
cules and their relationships to the coordi-
nation and interactions of oxygen radical
generation and degradation are important
issues to be dealt with in greater detail to
understand the synergistic concepts oflung
dieases. We hope that future conferences
will address these and other issues..
V.Vailythan
V. Castranova
K. Weber
National Institute ofOccupational
Safety and Health
Morgantown, West Virginia
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MTBE: Not Carcinogenic
Subsequent to publication of EHPs
timely article on the toxicological poten-
tial of methyl-tert-butyl ether (MTBE;
vol. 103, pp. 666-670), the long-await-
ed study from the Ramazzini Foun-
dation of Oncology and Environmental
Sciences appeared in print (1). This was
a landmark publication because for
months we in the scientific community
had been advised that the data predicted
dire health hazards for humans exposed
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to MTBE. According to the EHParticle,
several scientists held the hope that the
"Maltoni" work would clarify questions
about MTBE's carcinogenic potential.
Despite the enthusiasm ofsome scien-
tists for Belpoggi's results, the most curso-
ryexamination ofthe paper reveals critical
issues that show the data have been gross-
ly overinterpreted. Rather than predicting
a health hazard, the data indicate that rats
tolerate enormous daily oral doses of
MTBE without exhibiting evidence of
either tumor or nontumor pathology.
Leydig cell tumors in high-dose male
rats. According to Belpoggi et al., the
administration of MTBE as an olive oil
gavage to male rats (1.0 g/kg, 4 days per
week) was associated with a significant
increase in the incidence of Leydig cell
tumors. But examination of the total
information in the paper shows that the
reported effect cannot be attributed to
MTBE. The apparent association was due
to a survival differential between control
and dosed animals. Male rats administered
the highest dose ofMTBE survived longer
than the control group. It is well known
that Leydig cell tumor incidence is age
related. Thelonger a ratsurvives, the more
likely it is to have Leydig cell tumors.
Claiming this survival-related effect to be
indicative of a human health hazard
strains the bounds ofscientific logic. This
is particularly true since Leydig cell neo-
plasms are most likely unique to rats and
appear to have no predictive utility for
human carcinogenic responses (2).
Lymphoma andleukemia (combined)
infemale rats. Belpoggi et al. reported
that MTBE increased the incidence of
lymphomas and leukemias (combined)
in female rats. Since no mention was
made of the incidences of these neo-
plasms individually, one can only assume
that neither was significantly elevated.
The scientific validity of combining
lymphomas and leukemias for statistical
purposes is highly questionable. A
National Toxicology Program working
committee reviewed scientific guidelines
and criteria for the combination of neo-
plasms during the interpretation of
rodent carcinogenesis studies (3).
According to that group of experienced
pathologists, combining certain tumors
for statistical purposes is appropriate and
might afford enhanced insights into the
biological effects of the test chemical. In
other cases, however, combinations are
unjustifiable and can lead to overesti-
mates ofcarcinogenic potential.
According to the NTP panel, it is
reasonable to combine different types of
leukemias and to combine different
types oflymphomas. But it is not appro-
priate to combine leukemias with lym-
phomas. Treatment-associated increases
in the incidence of one or the other of
these tumors of diverse cellular origin
may be suggestive ofan oncogenic effect.
But, since the incidence of neither was
significantly and independently elevated,
the authors' interpretation of this por-
tion of the study represents an overesti-
mation ofcarcinogenic potential.
The science of carcinogenic hazard
identification and risk assessment has
progressed well beyond the days ofsim-
ply counting tumors and then making
grand leaps to unfounded and insup-
portable conclusions. As we expand our
understanding of chemical carcinogene-
sis and the predictive validity of our
experimental models, we must employ
critical and scientific thought processes
that incorporate the total knowledge
about the chemical. The total of perti-
nent knowledge about the carcinogenic
effects of MTBE in laboratory animals
shows that:
* The oral administration of up to 1
g/kg of MTBE four days a week pro-
duced neither neoplastic nor non-neo-
plastic changes in male and female rats,
* The chronic inhalational adminis-
tration ofgrossly toxic concentrations of
MTBE produced an increased incidence
of hepatocellular adenomas in female
(but not male) mice and an increased
incidence ofrenal tubular cell adenomas
and carcinomas (combined) in male (but
not female) rats,
* Neither MTBE nor its metabolite,
tertiary butyl alcohol, possess genotoxic
potential in either in vitro or in vivo
models,
* A potential metabolite of MTBE,
formaldehyde, possesses equivocal geno-
toxic potential in mammalian models, but
*Even when administered at inhala-
tional doses that are lethal to rats and
cytotoxic to mice, MTBE possesses no
genotoxic potential in in vivo mam-
malian models.
These scientific facts lead to the con-
clusions that supramaximal inhalational
doses of MTBE cause increased inci-
dences ofliver neoplasms in female mice
and renal neoplasms in male rats. But
since MTBE and its metabolites possess
no genotoxic potential, the proliferative
changes in response to toxic doses are
mediated through nongenotoxic mecha-
nisms that require cytotoxicity to precip-
itate proliferation. Because ofthe intense
odor (and taste) ofMTBE, humans will
not tolerate either air or water concentra-
tions sufficient to produce the cytotoxic
precursors required to promote cellular
proliferation. In short, the carcinogenic
hazard associated with MTBE has been
identified and defined. The human risk,
however, appears to be so small that it is
essentially nonexistent.
John H. Mennear
School ofPharmacy
Campbell University
Buies Creek, North Carolina
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Clarification: Chemical
Syngergism
In a recent EHPForum article ("Menace
in the Mix," vol. 103, pp. 792-793)
concerning Dr. Mohammed Abou-
Donia's work related to the Gulf War
syndrome, I am quoted as saying first
"It's a plausible hypothesis that syner-
gism occurred" and second "That's not
to say [the hypothesis] is an appropriate
lead for further investigation." Clearly
these two statements are contradictory,
and the second tends to place me in a
adversarial position relative to Abou-
Donia. All of this arose from a back-
ground discussion of synergism, of the
nature of hypotheses and how science
proceeds, not from a specific discussion
of Abou-Donia's work, since the latter
was not available to me.
My position, based on the prelimi-
nary statements that have appeared con-
cerning this work, is that it is interesting,
that it provides a plausible hypothesis,
and that it does indeed provide a basis
for further studies. I hope, and believe,
that nothing I said in the interview was
critical of the authors of this work and
did not go beyond what I would have
discussed with them in a friendly discus-
sion between fellow toxicologists.
Ernest Hodgson
Department ofToxicology
North Carolina State University
Raleigh, North Carolina
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